243 related articles for article (PubMed ID: 32084525)
21. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
Nieder C; Hess S; Lewitzki V
Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
[TBL] [Abstract][Full Text] [Related]
22. Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.
Tai CH; Wu CC; Hwang ME; Saraf A; Grubb C; Jani A; Lapa ME; Andrews JIS; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJ
CNS Oncol; 2018 Jan; 7(1):25-34. PubMed ID: 29392968
[TBL] [Abstract][Full Text] [Related]
23. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries.
Nieder C; Andratschke NH; Geinitz H; Grosu AL
Med Sci Monit; 2012 Jul; 18(7):CR450-5. PubMed ID: 22739735
[TBL] [Abstract][Full Text] [Related]
25. Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
Honda Y; Aruga T; Yamashita T; Miyamoto H; Horiguchi K; Kitagawa D; Idera N; Goto R; Kuroi K
Jpn J Clin Oncol; 2015 Aug; 45(8):713-8. PubMed ID: 25981620
[TBL] [Abstract][Full Text] [Related]
26. Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions.
Shi W; Li Y; Sun H; Zhang L; Meng J; Wang X; Chen X; Zhang X; Mei X; Ma J; Mo M; Zhou C; Liang F; Shao Z; Zhang Z; Guo X; Yu X; Yang Z
Radiat Oncol; 2023 Jul; 18(1):107. PubMed ID: 37393259
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
28. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
[TBL] [Abstract][Full Text] [Related]
29. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
30. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
31. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
32. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases.
Fabregat-Franco C; Stradella A; Navarro V; Linares J; Galdeano M; Recalde S; Velasco R; Simo M; Fernadez A; Venthecourt AC; Falo C; Vazquez S; Bergamino M; Villanueva R; Pernas S; Gil-Gil MJ
Clin Transl Oncol; 2021 Sep; 23(9):1761-1768. PubMed ID: 33704689
[TBL] [Abstract][Full Text] [Related]
33. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
[TBL] [Abstract][Full Text] [Related]
34. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
[TBL] [Abstract][Full Text] [Related]
35. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
[TBL] [Abstract][Full Text] [Related]
36. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A
BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939
[TBL] [Abstract][Full Text] [Related]
37. Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.
Nagtegaal SHJ; Claes A; Suijkerbuijk KPM; Schramel FMNH; Snijders TJ; Verhoeff JJC
Radiother Oncol; 2019 Sep; 138():173-179. PubMed ID: 31302392
[TBL] [Abstract][Full Text] [Related]
38. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract][Full Text] [Related]
39. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
40. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]